Quality-of-life issues in hemodialysis: Case studies on the use of sildenafil for Erectile Dysfunction

Julie A. Jacques; Carlos L. Abraira

Quality-of-life issues in hemodialysis: Case studies on the use of sildenafil for Erectile Dysfunction

Julie A. Jacques, Carlos L. Abraira

Medicine

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Hemodialysis patients are surviving longer and enjoying better overall health than at any time in the past. The result has been the highlighting of quality-of-life issues not previously addressed. This case study of the use of sildenafil (Viagra®) in four dialysis patients showed an average improvement of more than 1 point on 13 of 15 questions using the International Index of Erectile Dysfunction, and an average net improvement of more than 22 points in overall score. The outcome of this small study of sildenafil use in the treatment of erectile dysfunction of dialyzed end-stage renal failure patients provides early evidence that the drug is successful in this population.

Original language	English (US)
Pages (from-to)	518-524
Number of pages	7
Journal	Dialysis and Transplantation
Volume	28
Issue number	9
State	Published - Sep 1 1999

ASJC Scopus subject areas

Nephrology
Transplantation

Access to Document

Fingerprint Dive into the research topics of 'Quality-of-life issues in hemodialysis: Case studies on the use of sildenafil for Erectile Dysfunction'. Together they form a unique fingerprint.

Cite this

@article{9fde5f6197f64224bb0d3e64893bc6a1,

title = "Quality-of-life issues in hemodialysis: Case studies on the use of sildenafil for Erectile Dysfunction",

abstract = "Hemodialysis patients are surviving longer and enjoying better overall health than at any time in the past. The result has been the highlighting of quality-of-life issues not previously addressed. This case study of the use of sildenafil (Viagra{\textregistered}) in four dialysis patients showed an average improvement of more than 1 point on 13 of 15 questions using the International Index of Erectile Dysfunction, and an average net improvement of more than 22 points in overall score. The outcome of this small study of sildenafil use in the treatment of erectile dysfunction of dialyzed end-stage renal failure patients provides early evidence that the drug is successful in this population.",

author = "Jacques, {Julie A.} and Abraira, {Carlos L.}",

year = "1999",

month = sep,

day = "1",

language = "English (US)",

volume = "28",

pages = "518--524",

journal = "Dialysis and Transplantation",

issn = "0090-2934",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Quality-of-life issues in hemodialysis

T2 - Case studies on the use of sildenafil for Erectile Dysfunction

AU - Jacques, Julie A.

AU - Abraira, Carlos L.

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Hemodialysis patients are surviving longer and enjoying better overall health than at any time in the past. The result has been the highlighting of quality-of-life issues not previously addressed. This case study of the use of sildenafil (Viagra®) in four dialysis patients showed an average improvement of more than 1 point on 13 of 15 questions using the International Index of Erectile Dysfunction, and an average net improvement of more than 22 points in overall score. The outcome of this small study of sildenafil use in the treatment of erectile dysfunction of dialyzed end-stage renal failure patients provides early evidence that the drug is successful in this population.

AB - Hemodialysis patients are surviving longer and enjoying better overall health than at any time in the past. The result has been the highlighting of quality-of-life issues not previously addressed. This case study of the use of sildenafil (Viagra®) in four dialysis patients showed an average improvement of more than 1 point on 13 of 15 questions using the International Index of Erectile Dysfunction, and an average net improvement of more than 22 points in overall score. The outcome of this small study of sildenafil use in the treatment of erectile dysfunction of dialyzed end-stage renal failure patients provides early evidence that the drug is successful in this population.

UR - http://www.scopus.com/inward/record.url?scp=0032828556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032828556&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0032828556

VL - 28

SP - 518

EP - 524

JO - Dialysis and Transplantation

JF - Dialysis and Transplantation

SN - 0090-2934

IS - 9

ER -